Physician

Mark Garry Murray, M.D.

According to 2025 Medicare claims, Mark Murray, M.D. (NPI: 1669594974) practices allergy/immunology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Harrison, MS. This provider's primary affiliated billing organization is MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (NPI: 1902882251; TIN: 640502151) and primary practice location at 39540-9390.

Murray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 151 traditional Medicare patients, billed 16,349 HCPCS/CPT codes, and received $291,405 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 670 prescription claims across 113 beneficiaries totaling $270,097 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 65 claims. Open Payments data shows 56 records totaling $1,083. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $62,307 to $291,405. Similarly, Part D prescription costs have moved sharply higher in recent years, from $274,490 to $270,097. In contrast, DME billing represents a smaller volume and rose steadily, from $211 to $3,019.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	247	6,575	$62,307
2016	237	5,921	$55,730
2017	166	5,845	$51,821
2018	179	5,343	$50,816
2019	212	7,615	$86,894
2020	143	8,375	$137,978
2021	158	10,100	$195,813
2022	158	12,668	$263,916
2023	159	15,171	$316,881
2024	151	16,349	$291,405

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	609	$274,490
2016	126	667	$159,159
2017	93	503	$113,317
2018	96	510	$72,651
2019	113	711	$115,618
2020	97	516	$98,050
2021	83	420	$113,381
2022	87	503	$227,205
2023	95	615	$286,914
2024	113	670	$270,097

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$133
2016	N/R	18	$90
2017	N/R	17	$51
2018	N/R	N/R	N/R
2019	N/R	28	$94
2020	N/R	39	$58,076
2021	N/R	39	$62,004
2022	N/R	53	$85,245
2023	N/R	63	$102,607
2024	N/R	65	$101,048

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	126	$55
94010	Test to measure expiratory airflow and volume	33	51	$17
95165	Professional service for preparation and provision of 1 or more antigens	59	1,950	$9
95117	Professional service for multiple injections of allergen	30	643	$7
95115	Professional service for single injection of allergen	37	638	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	20	560	$76,891
Gammaked	Immune Globul G/Gly/Iga Avg 46	27	567	$71,927
Dupixent Pen	Dupilumab	12	336	$37,516
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	990	$19,835
Breo Ellipta	Fluticasone/Vilanterol	34	1,200	$15,265

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	24	$98,922
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	24	$1,126
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	17	$1,000

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$1,083	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Garry Murray, M.D.?

Tedicare shows public-source Medicare data for Mark Garry Murray, M.D. (NPI 1669594974), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Garry Murray, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Garry Murray, M.D.?

Mark Garry Murray, M.D. is linked to MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (billing NPI 1902882251) in the available physician profile data.

Does Mark Garry Murray, M.D. have Open Payments data?

Mark Garry Murray, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.